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Introduction: Standard anthropometric measures used to diagnose obesity in the general
population may not have the same performance in patients with rheumatoid arthritis.
Objective: To determine cutoff points for body mass index (BMI) and waist circumference
(WC) for detecting obesity in women with rheumatoid arthritis (RA) by comparing these
standard anthropometric measures to a dual-energy X-ray absorptiometry (DXA)-based
obesity criterion.
Patients and method: Adult female patients with more than six months of diagnosis of RA
underwent clinical evaluation, with anthropometric measures and body composition with
DXA.
Results: Eighty two patients were included, mean age 55 ± 10.7 years. The diagnosis of obesity
in  the sample was about 31.7% by BMI, 86.6% by WC and 59.8% by DXA. Considering DXA
as  golden standard, cutoff points were identiﬁed for anthropometric measures to better
2timates of percent body fat: for BMI value ≥ 25 kg/m was the best foriagnosis approximate DXA esPlease cite this article in press as: Guimarães MFBR, et al. Which is the best cutoff of body mass index to identify obesity in
female patients with rheumatoid arthritis? A study using dual energy X-ray absorptiometry body composition. Rev Bras Reumatol. 2016.
http://dx.doi.org/10.1016/j.rbre.2016.02.008
deﬁnition of obesity in female patients with RA, with sensitivity of 80% and speciﬁcity of
60%.  For WC,  with 80% of sensitivity and 35% of speciﬁcity, the best value to detect obesity
was  86 cm.
∗ Corresponding author.
E-mail: mfbresende@yahoo.com.br (M.F.B.R. Guimarães).
ttp://dx.doi.org/10.1016/j.rbre.2016.02.008
255-5021/© 2016 Elsevier Editora Ltda. All rights reserved.
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Conclusion: A large percentage of patients were obese. The traditional cutoff points used for
obesity were not suitable for our sample. For this female population with established RA,
BMI  cutoff point of 25 kg/m2 and WC cutoff point of 86 cm were the most appropriate to
detect  obesity.
© 2016 Elsevier Editora Ltda. All rights reserved.
Qual  o  melhor  ponto  de  corte  de  índice  de  massa  corporal  para
diagnosticar  a  obesidade  em  mulheres  com  artrite  reumatoide?  Um
estudo  que  usa  a  composic¸ão  corporal  pela  absorciometria  com  raios  X  de
dupla  energia
Palavras-chave:
Artrite reumatoide
Mulheres
Obesidade
Densitometria óssea
Composic¸ão corporal
Índice de massa corporal
Diagnóstico
r  e  s  u  m  o
Introduc¸ão: Medidas antropométricas universalmente usadas para diagnosticar obesidade
na  populac¸ão geral podem não apresentar a mesma performance em pacientes com artrite
reumatoide.
Objetivos: Determinar pontos de corte do índice de massa corporal (IMC) e da circunfer-
ência de cintura (CC) para detecc¸ão de obesidade em mulheres com artrite reumatoide
(AR) por meio da comparac¸ão dessas medidas antropométricas habituais com os índices
de  adiposidade obtidos pela densitometria óssea por dupla emissão de raios X (DXA).
Pacientes e método: Mulheres adultas com mais de seis meses de diagnóstico de AR foram
submetidas a avaliac¸ão clínica com medidas antropométricas e à DXA com exame da
composic¸ão  corporal.
Resultados: Foram incluídas 82 pacientes, média de 55±  10,7 anos. O diagnóstico de obesi-
dade  na amostra foi de 31,7% pelo IMC, 86,6% pela circunferência de cintura e 59,8% pela
DXA.  Considerando a DXA o padrão-ouro, o valor de IMC acima de 25 kg/m2 foi o mais ade-
quado para deﬁnic¸ão de obesidade nas pacientes com AR, apresentou sensibilidade de 80%
e  especiﬁcidade de 60%. Da mesma forma, para a CC, com 80% de sensibilidade e de 35% de
especiﬁcidade, o valor encontrado foi de 86 cm para se detectar a obesidade.
Conclusão: Foi elevado o porcentual de pacientes obesas. Os pontos de corte tradi-
cionalmente usados para obesidade não foram adequados para nossa amostra. Para essa
populac¸ão  de pacientes femininas com diagnóstico de AR, o ponto de corte de 25 kg/m2 para
IMC e de 86 cm para CC foi o mais adequado para deﬁnir obesidade.
© 2016 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Obesity and rheumatoid arthritis (RA) have been shown to
be related in different ways. The ﬁrst condition seems to be
related to an increased risk of development of the second dis-
ease. Recent meta-analysis that included 11 studies showed
that obese subjects with BMI  ≥ 30 kg/m2 had a higher relative
risk for developing RA.1
In patients with the established disease, the inﬂammatory
process is able of altering body composition, leading to obesity
with increased abdominal fat and loss of lean body mass.2
This decrease in lean body mass, along with the increase in fat
mass and in central obesity, may be related to the increased
cardiovascular morbidity and also with functional decline.3
In cases of RA, the occurrence of body fat accumu-
lation without a signiﬁcant increase in body weight is a
4,5Please cite this article in press as: Guimarães MFBR, et al. Which
female patients with rheumatoid arthritis? A study using dual energy 
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condition known as rheumatoid cachexia, whose esti-
mated prevalence ranges from 10 to 67%.6 In a setting
of chronic inﬂammation, high levels of cytokines causemetabolic changes, which can result in the alterations above
mentioned.7,8
Moreover, according to the US Center of Disease Control
(CDC),9 the prevalence of obesity in patients with rheumatoid
arthritis is 54% higher than in RA-free individuals. A multicen-
ter study found a prevalence of 18% of obesity in a population
with RA,10 while another study found a prevalence of 31%.11
Epidemiological data considered RA as an independent risk
factor for cardiovascular disease (CVD), and one of the main
causes of death in patients with that disease.12–14 A meta-
analysis of 24 studies of patients with RA showed an increase
of 50% in the risk of death from cardiovascular causes in
general.15
Obesity can contribute to increasing the risk of CVD
development as well as of type II diabetes mellitus (DM  II),
dyslipidemia, and hypertension (HBP).16,17
Overweight in RA patients has been associated with is the best cutoff of body mass index to identify obesity in
X-ray absorptiometry body composition. Rev Bras Reumatol. 2016.
increased mortality, increased pain, worse quality of life,
an increase in indications for the use of joint prostheses,
and increased costs with the disease.18,19 Obesity can also
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determined using ROC curves, and with the ﬁnding of pointsr  e v b r a s r e u m a t o l
egatively inﬂuence the course of the disease, functional
apacity of patients, as well as disease activity.18,20 Obese
atients are not-so good respondents to the use of anti-TNF
gents, and are less likely to achieve remission with the use
f these drugs.21 One study found a decreased response to
reatment with a combination of synthetic disease-modifying
nti-rheumatic drugs in patients with high BMIs.22
Obesity, deﬁned as an increase in fat in sufﬁcient level
o cause adverse health consequences, is usually diagnosed
y anthropometric measurements of body mass index (BMI),
hich is calculated as weight in kilograms divided by the
quare of height in meters (kg/m2), and of waist circumference
WC).23
BMI  is easy to perform and a good indicator of obesity,
ut does not have an accurate correlation with body fat.
his indicator is not able to distinguish between fat mass
nd lean mass, and do not necessarily reﬂects the distribu-
ion of body fat.24 Identifying fat distribution is important in
he evaluation of overweight and obesity, as visceral (intra-
bdominal) fat is a risk factor for CVD, regardless of total body
at. Individuals with the same BMI  may have different lev-
ls of visceral fat mass; and this relationship between weight
nd height may not be able to reﬂect those body composi-
ion changes often found in patients with RA.8 For a given
alue of BMI, body fat may differ, and there is evidence of
igher percentages of body fat in patients with RA versus
ontrols.25
Dual-energy X-ray absorptiometry (DXA) is a more  accurate
ethod than BMI  measurement to assess body composi-
ion, both in young and in older subjects; this method is
ensitive to small changes in body composition.26–28 In RA
atients, the assessment of body composition by DXA was
bnormal, with a decrease in lean body mass and an increase
f fat mass, especially in patients within normal range for
MI.29,30
The aim of this study is to evaluate the correlation between
onventional anthropometric measurements (BMI and WC)
nd total fat percentage and adiposity indexes obtained
hrough body composition by DXA. Another objective is to
dentify the need of, and determine, new cutoff points for BMI
nd WC for obesity detection in women with RA.
atients  and  methods
emale patients with rheumatoid arthritis deﬁned accord-
ng to the American College of Rheumatology (ACR) 198731
r to ACR/EULAR 201032 classiﬁcation criteria, with over six
onths of symptoms, and aged over 18 years old were con-
ecutively invited to participate in this study. Patients with
ther connective tissue diseases (overlap syndromes), except
or secondary Sjögren’s syndrome; with presence of a pace-
aker, implanted deﬁbrillator, and orthopedic prosthesis, or
ny metallic object (pins, screws) from orthopedic surgery
ere excluded from this study, due to interference in bodyPlease cite this article in press as: Guimarães MFBR, et al. Which
female patients with rheumatoid arthritis? A study using dual energy 
http://dx.doi.org/10.1016/j.rbre.2016.02.008
omposition examination by DXA. Before performing any pro-
edure, all participants signed a informed consent form (FICF)
reviously approved by the Research Ethics Committee of
FMG. 6;x  x x(x x):xxx–xxx 3
All patients underwent clinical evaluation, which included
swollen/painful joint counts. Information related to the
disease, diagnostic criteria, clinical and laboratory manifes-
tations, the presence of extra-articular manifestations,
comorbidities, and current and previous treatments,
was obtained from an interview and by medical record
review.
Anthropometric measurements and bone densitometry
with body composition were performed on the same assess-
ment day. The participants were weighed barefooted and
without heavy clothing on a Filizola scale (1–200 kg, with an
error margin of 50 g) intended exclusively for weighing peo-
ple. The subject’s height was measured with the stadiometer
coupled to the same Filizola scale. The BMI calculation was
performed according to the formula: BMI = weight (kg)/height
(m2).
The following BMI ranges were adopted: normal,
BMI  = 18.5–24.9 kg/m2; overweight, BMI  = 25–29.9 kg/m2;
and obesity, BMI  ≥ 30 kg/m2, as recommended by the World
Health Organization.33
WC was performed using a plastic tape measure, which
was applied midway between the lowest rib and the iliac crest
with the subject standing, and represented the horizontal dis-
tance around the abdomen. Presence of abdominal or central
obesity was considered in women whose waist circumfer-
ence ≥ 80 cm.34
We  also calculated the conicity index, which is another
way to estimate abdominal obesity. This index was developed
from a geometric ratio model, and was calculated using the
patient’s waist circumference, weight and height through the
following formula:35
waist circumference(cm)
0.109 ×
√
weight(kg)
height(m)
Body composition was measured by DXA (Discovery W
Hologic densitometer [Bedford, MA, USA], v. 3.3.0), and
the results were always interpreted by the same trained
researcher. The measurements were performed with the sub-
ject supine, after removing all metal ﬁttings, and lasted six
minutes. We used Bray GA’s deﬁnition of obesity by DXA,
that considers the patient’s gender and age group. In this
deﬁnition, the percentage of fat considered representative of
obesity varies from 39 to 43% in women, according to their age
group.36
Statistical  analysis
The descriptive analysis was performed using mean and
standard deviation for continuous variables and percentages
for binary variables. Anthropometric variables were correlated
(Spearman method) to total fat percentage observed with DXA.
The optimal cutoff points of anthropometric variables were is the best cutoff of body mass index to identify obesity in
X-ray absorptiometry body composition. Rev Bras Reumatol. 2016.
that determined preset sensitivities of 80% and 90% for detec-
tion of obesity diagnosed with DXA.
The calculations were performed using the R software v3.
1.237 and ROC curves were plotted using ROCR library.38
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Table 1 – Demographic and clinical characteristics of
study population.
Demographics and factors related to
disease
n  = 82
Age (years) – mean (SD) 55.24 (10.77)
Disease duration (years) – mean (SD) 16.89 (9.08)
Extra-articular manifestations (%) 16.0 (n = 75)
Fatigue (%) 32.9
DAS28 – median (quartile 1; quartile 3) 3.9 (3.0; 5.2)
HAQ – median (quartile 1; quartile 3) 1.0 (0.2; 1.6)
RA, seropositive (%) 79.2 (n = 72)
Anthropometric data
Weight (kg) – mean (SD) 65.48 (12.29)
Height (cm) – mean (SD) 154.90 (6.79)
Waist circumference (cm) – mean
(SD)
93.99  (12.20)
BMI (kg/m2) – mean (SD) 27.20 (4.30)
Total fat obtained by DXA (%) –
mean (SD)
42.78  (5.23)
Obesity – DXA (%) 59.8
Obesity – BMI (%) 31.7
Obesity – waist circumference (%) 86.6
Inﬂammatory activity
ESR (mm/h) – median (quartile 1,
quartile 3)
21.5  (14.0; 35.5)
CRP (mg/L) – median (quartile 1,
quartile 3)
9.2  (5.9; 17.0)
Comorbidities
Smoking (%) 29.3
Hypertension (%) 58.5
Diabetes mellitus (%) 15.9
Dyslipidemia (%) 48.8
Metabolic syndrome (%) 51.2
Medications
Lipid-lowering agents (%) 39.2 (n = 74)
Anti-hypertensives (%) 59.8
Anti-diabetic drugs (%) 14.6
Anti-TNF agents (%) 18.7 (n = 75)
NSAIDs, regular use (%) 20.0 (n = 75)
Biologicals (including anti-TNF) (%) 23.5 (n = 68)
Prednisone (%) 63.4
Prednisone dose (mg/day) – median
(quartile 1, quartile 3)
5.0  (5.0; 10.0)
Standard deviation in parentheses for continuous variables.
DAS28, Disease Activity Score; HAQ, Health Assessment Ques-
tionnaire; RA, rheumatoid arthritis; BMI, body mass index; DXA,
dual-energy X-ray absorptiometry; ESR, erythrocyte sedimentation
Table 2 – Spearman correlation between anthropometric
measurements for waist circumference and body mass
index and total fat percentage obtained by DXA.
Women
(n = 82)
Waist circumference (cm) 0.482+
BMI (kg/m2) 0.510*
+ p < 0.05.
∗ p < 0.001.
Table 3 – Sensitivity and speciﬁcity BMI  (kg/m2) in
obesity detection diagnosed by DXA. Usual cutoff point
(BMI = 30) and optimal points found.
Women (n = 82)
BMI Speciﬁcity Sensibility
30 76% 37%
25 58% 82%
23 36% 92%rate; TNF, tumor necrosis factor; NSAIDs, nonsteroidal anti-
inﬂammatory drug.
Ethics
This study was approved by the Research Ethics Committee of
Universidade Federal de Minas Gerais (UFMG) on January 10,
2012, with an addendum and FICF approved on February 20,
2013.Please cite this article in press as: Guimarães MFBR, et al. Which
female patients with rheumatoid arthritis? A study using dual energy 
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Results
Eighty-two women with mean age 55 ± 10.7 years and mean
disease duration of 16 ± 9.08 years, were included in this study.This cohort had a mean BMI of 27.2 ± 4.3 kg/m2, a mean waist
circumference of 94 ± 12.2 cm,  and a mean conicity index of
1.33. The demographic characteristics and factors related to
the disease are listed in Table 1. The obesity rate found varied
according to different criteria: 31.7% by BMI, 86.6% by WC,  and
59.8% by DXA. The correlations between the following clini-
cal variables were evaluated: disease duration, DAS28, HAQ,
CRP, ESR and cumulative dose of prednisone, both with BMI
and with body fat by DXA. None of these correlations was
statistically signiﬁcant.
Table 2 shows Spearman correlations between total fat per-
centage obtained by DXA and WC and BMI. One can perceive
that all correlations obtained were signiﬁcant (  ˛ = 5%) and BMI
correlated more  strongly with total fat percentage obtained
by DXA versus by WC.  The correlation between conicity index
and total fat by DXA was also positive, with statistical signif-
icance (+0.2350 with p = 0.019); however, this value was lower
than that for the correlation with BMI.
To determine the optimal cutoff points of BMI and WC
for obesity detection in patients with RA, the construction of
ROC curves showed cutoff values presenting 80% and 90% of
sensitivity. The ROC curves show that, for the desired sen-
sitivity values, BMI is a better discriminator of obesity than
WC,  thanks to its higher speciﬁcity for the same sensitivity
values.
The cutoff point normally used for BMI in assessing obesity
(BMI = 30 kg/m2) showed low sensitivity for detecting disease
in this sample (Table 3), identifying only 37% of obese patients
in the analyzed group. One can observe that a cutoff around
25 would be more  appropriate for patients with RA, as this
value has a high sensitivity (80%) with speciﬁcity around 60%. is the best cutoff of body mass index to identify obesity in
X-ray absorptiometry body composition. Rev Bras Reumatol. 2016.
Regarding WC,  the cutoff point of 80 cm for women is very
sensitive (96%), but lacks speciﬁcity (only 18%) (Table 4). The
WC cutoff point for detecting obesity with 82% of sensitivity
is 86 cm.  This cutoff point has a speciﬁcity of 36%.
ARTICLE IN PRESSRBRE-265; No. of Pages 7
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Table 4 – Sensitivity and speciﬁcity of waist
circumference (cm) in obesity detection diagnosed by
DXA. Usual cutoff point (80 cm for women) and optimal
points found.
Women (n = 82)
Waist circumference Speciﬁcity Sensibility
80 18% 96%
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82 27% 92%
iscussion
he obesity rate in this population of patients with RA was
igh; about one third with the use of the BMI deﬁnition, 60% by
XA, and more  than 80% according to WC.  The study by Giles
t al.30 reported that 33% of women and 36% of men  with RA
ere regarded as obese by BMI, and 57% of these patients were
eemed obese by DXA. Katz et al. have described obesity by
MI  in 28.4%; on the other hand, these authors reached 58.2%
y DXA in the population studied.39 In relation to obesity fre-
uency by WC,  the value found was higher than that described
n the literature.24 With the use of WC,  Katz et al. used the
besity criterion of 88 cm for women,39,40 whereas the present
tudy used a cutoff point of 80 cm by WC – a level more  recently
ecommended by the International Diabetes Federation (IDF)
n 2006.34
When using DXA as the gold standard for detection of
besity, we  realize that the prevalence of this condition was
nderestimated by BMI  and overestimated by WC.  The use
f a BMI  > 30 kg/m2 had a sensitivity < 40%; and the use of
C > 80 cm for women showed speciﬁcity < 20%, clearly an
verestimate of the number of obese women in the study
roup.
One possible explanation for the underestimation seen
ith the use of BMI  is that this indicator lacks the ability to
onsider the loss of lean body mass concomitantly to fat mass
ain in individuals with RA. As for WC,  it may be that its rec-
mmended threshold for women is unreasonably low (80 cm),
 value which lacks speciﬁcity.
In determining the cutoff points of BMI  and WC for this
emale population with RA, we employed sensitivity values of
0 and 90%, because our understanding is that these anthro-
ometric measurements should be used to screen patients
ith RA; therefore, a high sensitivity is a critical factor. Then,
e compared our ﬁndings to those commonly used as cut-
ff points of BMI  and WC,  achieving the new cutoff points
uggested in the results.
Our results suggest the use of a BMI > 25 kg/m2 as the
hreshold for women, because this value resulted in a sen-
itivity of 82% and in a speciﬁcity of 58% in the diagnosis of
besity. For WC,  we  suggest the use of 86 cm for deﬁnition of
besity, resulting in 82% of sensitivity and 36% of speciﬁcity.
The results found in this study are in line with those of
ther authors who  suggest reviewing cutoff points of BMI  and
C in patients with RA. Katz et al. proposed a cutoff point forPlease cite this article in press as: Guimarães MFBR, et al. Which
female patients with rheumatoid arthritis? A study using dual energy 
http://dx.doi.org/10.1016/j.rbre.2016.02.008
besity in women of 26.1 kg/m2 for BMI  and of 83 cm for WC.24
tavropoulos-Kalinoglou et al. suggested a decrease of 2 kg/m2
n BMI  for RA patients, in order to establish the presence of 6;x  x x(x x):xxx–xxx 5
obesity.4 In this way, one perceives a universal acceptance
of the concept that obesity in RA patients must be handled
in an early and intensive manner. Loss of muscle mass and
fat inﬁltration in the muscle, resulting from inﬂammation,
may explain the higher percentage of fat, despite a BMI  value
within the normal range.
One limitation of our study is its sample size; this suggests
that the results obtained are waiting for external validation.
The non-inclusion of male patients is another important
limitation. It is noteworthy, however, that the prevalence of
female patients seems to constitute the absolute majority in
RA cohorts in our population. In the multinational cohort of
Latin-American patients (GLADAR), the prevalence of female
patients was 85%.41 Another aspect to consider is that in our
study a group of patients was excluded for lacking the ability to
be examined by DXA; this may have left out a group of patients
with comorbidities, or with a disease of greater severity.
This sample consisted of patients with long disease
duration (mean, 16 years) and high prevalence for use of
corticosteroids (63.4%). The statistical analysis showed no
correlation between disease duration or cumulative dose of
corticosteroids with BMI or with total fat percentage measured
by DXA. In our study, it was found that body fat is increased
in a group of long-term RA patients, and other authors have
demonstrated that even patients with early RA have their total
fat increased when measured by DXA versus controls.42
Conclusions
Considering DXA as the gold standard, the cutoff points con-
ventionally used for obesity through anthropometric indexes
were not suitable for our RA patients.
BMI was the best predictor of obesity in patients with RA
versus WC,  showing a better correlation with total fat per-
centage obtained by DXA. BMI  values above 25 kg/m2 suggest
alertness to optimize the treatment by strengthening the goals
for steroid discontinuation, to ﬁght against sedentary lifestyle,
and nutritional guidance.
It is suggested that this new BMI  cutoff point should be
adopted in clinical practice when approaching female patients
with RA, in order to identify those overweight subjects and also
to promote intensive interventions for better cardiovascular
outcomes.
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